207 related articles for article (PubMed ID: 24256629)
1. High rates of tuberculosis in patients accessing HAART in rural South Africa.
Naidoo K; Karim QA; Bhushan A; Naidoo K; Yende-Zuma N; McHunu PK; Frohlich J; Karim F; Upfold M; Kocheleff P; Abdool Karim SS
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):438-46. PubMed ID: 24256629
[TBL] [Abstract][Full Text] [Related]
2. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.
Martinson NA; Moultrie H; van Niekerk R; Barry G; Coovadia A; Cotton M; Violari A; Gray GE; Chaisson RE; McIntyre JA; Meyers T
Int J Tuberc Lung Dis; 2009 Jul; 13(7):862-7. PubMed ID: 19555536
[TBL] [Abstract][Full Text] [Related]
3. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.
Dembélé M; Saleri N; Carvalho AC; Saouadogo T; Hien AD; Zabsonre I; Koala ST; Simporé J; Matteelli A
Int J Tuberc Lung Dis; 2010 Mar; 14(3):318-23. PubMed ID: 20132623
[TBL] [Abstract][Full Text] [Related]
4. The tuberculosis challenge in a rural South African HIV programme.
Houlihan CF; Mutevedzi PC; Lessells RJ; Cooke GS; Tanser FC; Newell ML
BMC Infect Dis; 2010 Feb; 10():23. PubMed ID: 20146818
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?
Pettit AC; Jenkins CA; Stinnette SE; Rebeiro PF; Blackwell RB; Raffanti SP; Shepherd BE; Sterling TR
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):305-10. PubMed ID: 21423024
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.
Girardi E; Sabin CA; d'Arminio Monforte A; Hogg B; Phillips AN; Gill MJ; Dabis F; Reiss P; Kirk O; Bernasconi E; Grabar S; Justice A; Staszewski S; Fätkenheuer G; Sterne JA;
Clin Infect Dis; 2005 Dec; 41(12):1772-82. PubMed ID: 16288403
[TBL] [Abstract][Full Text] [Related]
7. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.
Yen YF; Jen IA; Chuang PH; Chen M; Lan YC; Lee CY; Arthur Chen YM
Ann Epidemiol; 2018 Dec; 28(12):886-892.e3. PubMed ID: 29656849
[TBL] [Abstract][Full Text] [Related]
8. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature.
Barr DA; Ramdial PK
BMC Infect Dis; 2012 Oct; 12():257. PubMed ID: 23061403
[TBL] [Abstract][Full Text] [Related]
10. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.
Alvarez-Uria G; Pakam R; Midde M; Naik PK
J Int AIDS Soc; 2014; 17(1):19251. PubMed ID: 25499123
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
[TBL] [Abstract][Full Text] [Related]
12. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.
Miranda A; Morgan M; Jamal L; Laserson K; Barreira D; Silva G; Santos J; Wells C; Paine P; Garrett D
PLoS One; 2007 Sep; 2(9):e826. PubMed ID: 17786198
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
14. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.
Bonnet MM; Pinoges LL; Varaine FF; Oberhauser BB; O'Brien DD; Kebede YY; Hewison CC; Zachariah RR; Ferradini LL
AIDS; 2006 Jun; 20(9):1275-9. PubMed ID: 16816556
[TBL] [Abstract][Full Text] [Related]
16. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
Lawn SD; Myer L; Bekker LG; Wood R
AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
[TBL] [Abstract][Full Text] [Related]
17. Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study.
Gandhi NR; Moll AP; Lalloo U; Pawinski R; Zeller K; Moodley P; Meyer E; Friedland G;
J Acquir Immune Defic Syndr; 2009 Jan; 50(1):37-43. PubMed ID: 19295333
[TBL] [Abstract][Full Text] [Related]
18. Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
Schmaltz CA; Santoro-Lopes G; Lourenço MC; Morgado MG; Velasque Lde S; Rolla VC
PLoS One; 2012; 7(9):e45704. PubMed ID: 23049842
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy.
Westreich DJ; Sanne I; Maskew M; Malope-Kgokong B; Conradie F; Majuba P; Funk MJ; Kaufman JS; Van Rie A; Macphail P
Clin Infect Dis; 2009 Jun; 48(11):1617-23. PubMed ID: 19385733
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
